» Articles » PMID: 16428408

Biochemical Analysis of Lpt3, a Protein Responsible for Phosphoethanolamine Addition to Lipooligosaccharide of Pathogenic Neisseria

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2006 Jan 24
PMID 16428408
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The inner core of neisserial lipooligosaccharide (LOS) contains heptose residues that can be decorated by phosphoethanolamine (PEA). PEA modification of heptose II (HepII) can occur at the 3, 6, or 7 position(s). We used a genomic DNA sequence of lpt3, derived from Neisseria meningitidis MC58, to search the genomic sequence of N. gonorrhoeae FA1090 and identified a homolog of lpt3 in N. gonorrhoeae. A PCR amplicon containing lpt3 was amplified from F62DeltaLgtA, cloned, mutagenized, and inserted into the chromosome of N. gonorrhoeae strain F62DeltaLgtA, producing strain F62DeltaLgtAlpt3::Tn5. LOS isolated from this strain lost the ability to bind monoclonal antibody (MAb) 2-1-L8. Complementation of this mutation by genetic removal of the transposon insertion restored MAb 2-1-L8 binding. Mass spectrometry analysis of LOS isolated from the F62DeltaLgtA indicated that this strain contained two PEA modifications on its LOS. F62DeltaLgtAlpt3::Tn5 lacked a PEA modification on its LOS, a finding consistent with the hypothesis that lpt3 encodes a protein mediating PEA addition onto gonococcal LOS. The DNA encoding lpt3 was cloned into an expression vector and Lpt3 was purified. Purified Lpt3 was able to mediate the addition of PEA to LOS isolated from F62DeltaLgtAlpt3::Tn5.

Citing Articles

Comparison of lipooligosaccharides from human challenge strains of .

John C, Phillips N, Cardenas A, Criss A, Jarvis G Front Microbiol. 2023; 14:1215946.

PMID: 37779694 PMC: 10540682. DOI: 10.3389/fmicb.2023.1215946.


Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria.

Thai V, Stubbs K, Sarkar-Tyson M, Kahler C Antibiotics (Basel). 2023; 12(9).

PMID: 37760679 PMC: 10525099. DOI: 10.3390/antibiotics12091382.


Analysis of Bacterial Phosphorylcholine-Related Genes Reveals an Association between Type-Specific Biosynthesis Pathways and Biomolecules Targeted for Phosphorylcholine Modification.

Zhang Y, Jen F, Edwards J, Jennings M Microbiol Spectr. 2023; 11(4):e0158323.

PMID: 37436144 PMC: 10434233. DOI: 10.1128/spectrum.01583-23.


Sequence-based predictions of lipooligosaccharide diversity in the Neisseriaceae and their implication in pathogenicity.

Stein D, Miller C, Bhoopalan S, Sommer D PLoS One. 2011; 6(4):e18923.

PMID: 21533118 PMC: 3078933. DOI: 10.1371/journal.pone.0018923.


Functional characterization of Lpt3 and Lpt6, the inner-core lipooligosaccharide phosphoethanolamine transferases from Neisseria meningitidis.

Wenzel C, St Michael F, Stupak J, Li J, Cox A, Richards J J Bacteriol. 2009; 192(1):208-16.

PMID: 19854897 PMC: 2798236. DOI: 10.1128/JB.00558-09.


References
1.
Gibson B, WEBB J, Yamasaki R, Fisher S, Burlingame A, Mandrell R . Structure and heterogeneity of the oligosaccharides from the lipopolysaccharides of a pyocin-resistant Neisseria gonorrhoeae. Proc Natl Acad Sci U S A. 1989; 86(1):17-21. PMC: 286394. DOI: 10.1073/pnas.86.1.17. View

2.
Hitchcock P, Brown T . Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 1983; 154(1):269-77. PMC: 217456. DOI: 10.1128/jb.154.1.269-277.1983. View

3.
Stein D . Transformation of Neisseria gonorrhoeae: physical requirements of the transforming DNA. Can J Microbiol. 1991; 37(5):345-9. DOI: 10.1139/m91-056. View

4.
John C, Griffiss J, Apicella M, Mandrell R, Gibson B . The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. J Biol Chem. 1991; 266(29):19303-11. View

5.
Yamasaki R, Nasholds W, Schneider H, Apicella M . Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components. Mol Immunol. 1991; 28(11):1233-42. DOI: 10.1016/0161-5890(91)90010-h. View